# Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cetuximab-combined-with-vemurafenib-can-significantly-inhibit-the-proli-feration/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Li Wan,Linghui Kong,Ding Zhou,Jing Hu,Shi Xiao,Li Li,Qun Zhang,Xiaoping Qian |
| Citations | 0 |
| DOI | 10.24205/03276716.2020.1106 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3166557721 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jing Hu](https://scholariq.org/researchers/jing-hu/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.